Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serum

• Published in: Neurochemistry international Vol. 108; pp. 303 - 308
• Main Authors: Neergaard, Jesper S., Dragsbæk, Katrine, Christiansen, Claus, Nielsen, Henning B., Workman, Christopher T., Brix, Susanne, Henriksen, Kim, Karsdal, Morten A.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.09.2017
• Subjects: Aged; Aged, 80 and over; Biomarkers - blood; Blood Brain Barrier; Blood-based biomarkers; Brain - metabolism; Brain - pathology; Cognition Disorders - blood; Cognition Disorders - diagnosis; Cohort Studies; Denmark - epidemiology; Female; Humans; Middle Aged; Neurodegeneration; Neurodegenerative Diseases - blood; Neurodegenerative Diseases - diagnosis; Neuropsychological Tests; Prospective Studies; Registries; Risk Factors; Tau; tau Proteins - blood; Tau; Blood-based biomarkers; Neurodegeneration; Blood Brain Barrier
• ISSN: 0197-0186; 1872-9754
• DOI: 10.1016/j.neuint.2017.05.002

There has been limited success with blood-based biomarkers of neurodegeneration. One perceived reason is that blood has no direct contact to the brain. Recently developed blood-based biomarkers of tau-degradation have shown promise as potential tools for peripheral assessment of neurodegeneration; however, factors contributing to the levels of these in blood are poorly understood. Using multiple linear regression analysis in cross-sectional data from an observational cohort (n = 5626), the aim was to examine which factors correlate to the serological levels of two novel biomarkers measuring truncated tau fragments (Tau-A and Tau-C) in serum. Platelets, albumin and several modifiable risk factors, including Body Mass Index, high density lipoprotein and white blood cell count were associated with the serum level of tau fragments. The factors associated with tau in serum may promote neurodegeneration and alter the permeability of the Blood Brain Barrier through chronic inflammation and vascular dysfunction. These data are of key importance for understanding the mechanism of release and subsequent peripheral processing of tau from the brain and will assist in the development of future blood-based biomarkers. •The biomarker levels were associated with several modifiable risk factors.•The factors may promote neurodegeneration through inflammation or vascular dysfunction.•Serum levels of Tau-A and Tau-C showed an inverse association with verbal fluency.